Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
6
×
life sciences
national blog main
national top stories
6
×
national
new york blog main
new york top stories
boston blog main
boston top stories
clinical trials
novartis
san francisco top stories
deals
europe blog main
europe top stories
san francisco blog main
amgen
asklepios biopharmaceutical
biogen
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
investing
ipo
migraine
raleigh-durham blog main
raleigh-durham top stories
roboticsai
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
What
new
6
×
fda
medicines
approved
bio
drug
ipo
life
roundup
science
acquire
activity
adults
agreed
allergan
approvals
arrival
atrophy
bails
billion
biogen
biotech
brand
bridgebio
brings
capital
car
cash
cholesterol
clamped
class
companies
company
compound
covid
daily
days
deal
delays
develop
Language
unset
6
×
Current search:
unset
×
fda
×
new
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
